Welcome : Guest

Vericel Corporation (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Vericel Corporation, which is principally involved in Developing Patient-Specific Expanded Cellular Therapies. Illustrated with 68 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-65678
Price: $3400
Company Type: Public
Pages: 73
Date: November 2016
Market Data Tables: 68

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Vericel Corporation's Sales by Product Segment (2014-2015) in Percentage for Carticel, Epicel, and Others......3
Table 2: Vericel Corporation’s Sales by Product Segment (2014) in Percentage for Carticel, Epicel, Bone Marrow and MACI (Matrix Applied Characterized Autologous Cultured Chondrocytes)......4
Gene Therapy......7
Table 3: Gene Therapy Clinical Trials Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Phase I, n=1183, Phase I/II, n=384, Phase II, n=330, Phase II/III, n=20 and Phase III, n=74......7
Plasma......8
Table 4: Plasma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Coagulation Factor IX, Coagulation Factor VIII, Fibrinogen, Human Albumin, Intravenous Immunoglobulin (IVIG), Specific Immunoglobulin and Others......8
Table 5: Plasma Market by Product Worldwide (2015) - Percentage Breakdown by Value for Albumin, Factor IX, Factor VIII, Hyperimmunes, Intravenous Immunoglobulin (IVIG), and Others......9
Table 6: Plasma Market by Products (excluding Recombinant Factors) Worldwide (2015) - Percentage Share Breakdown by Value for Albumin, Factor VIII, Intravenous Immunoglobulin (IVIG) and Others......10
Table 7: Plasma Market by Region (excluding Recombinant Factors) Worldwide (2015) - Percentage Share Breakdown by Value for Asia-Pacific, Europe, North America and Others......11
Table 8: Plasma Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Europe, and Middle East, USA, and Others......12
Table 9: Blood Plasma Composition by Category Worldwide (2015) - Percentage Share Breakdown by Volume for Protein, Water, and Others......13
Table 10: Plasma Market by Segment in China (2015) - Percentage Share Breakdown by Value for Alpha-1 Proteinase Inhibitor (A1PI), Coagulation Factor IX, Coagulation Factor VIII, Fibrinogen, Human Albumin, Immunoglobulin for Intramuscular Injection, Intravenous Immunoglobulin (IVIG), Prothrombin Complex, and Specific Immunoglobulin......14
Table 11: Plasma Market by Type in China (2015) - Percentage Share Breakdown by Value for Blood Coagulation Factor, Fibrinogen, Human Albumin, Human Immunoglobin and Hyperimmunes and Others......15
Genetic Testing......16
Table 12: Genetic Test Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Exome, Mendeliome, Small Panel, and Whole Genome......16
Table 13: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Cancer, Neurology, Pediatric Development, and Others......17
Table 14: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detection, Predisposition, Treatment Selection, Monitoring, and Others......18
Genomic Technology......19
Table 15: Genomic Technology (Academic, Government, Applied Markets, Biopharma, Diagnostic Labs) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......19
Table 16: Genomic Technology for Applied Markets Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......20
Table 17: Genomic Technology for Biopharma Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......21
Table 18: Genomic Technology for Diagnostic Labs Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......22
Table 19: Genomic Technology for Academic/Government Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......23
Genomic Tools......24
Table 20: Genomics Tools Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for DNA Microarrays, Fluorescent in Situ Hybridization (FISH), Polymerase Chain Reaction (PCR), Sequencing, and Miscellaneous Reagents......24
Genomics 2.0......25
Table 21: Genomics 2.0 Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......25
Table 22: Genomics 2.0 Market for Oncology by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......26
Table 23: Genomics 2.0 for Reproductive Health Carrier Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......27
Table 24: Genomics 2.0 for Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......28
Table 25: Genomics 2.0 for Consumer Genomics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......29
Table 26: Genomics 2.0 for Forensics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......30
Table 27: Genomics 2.0 for Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......31
Table 28: Genomics 2.0 for In Vitro Fertilization (IVF) Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......32
Table 29: Genomics 2.0 for Livestock and Agriculture Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......33
Table 30: Genomics 2.0 for Microbiology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......34
Table 31: Genomics 2.0 for Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......35
Table 32: Genomics 2.0 for Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......36
Table 33: Genomics 2.0 for Reproductive Health Non-Invasive Prenatal Testing (NIPT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......37
Table 34: Genomics 2.0 for Transplant, Human leukocyte antigen (HLA) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......38
Table 35: Genomics 2.0 Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......39
Oncology Genomics......40
Table 36: Oncology Genomics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......40
Table 37: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......41
Table 38: Oncology Genomics Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......42
Stem Cell Transplantation......43
Table 39: Stem Cell Transplantation Market by Category for American Indian and Alaskan Natives in the US (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......43
Table 40: Stem Cell Transplantation Market by Category for Asians in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......44
Table 41: Stem Cell Transplant Market by Category for Black and African Americans in the US (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......45
Table 42: Stem Cell Transplantation Market by Category for Native Hawalian and Other Pacific Islanders in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......46
Table 43: Stem Cell Transplantation Market by Category for Whites in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......47
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)......48
Table 44: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Leukemia by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......48
Table 45: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Bone Marrow Failure by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......49
Table 46: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Leukemia by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......50
Table 47: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Leukemias by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......51
Table 48: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoma by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......52
Table 49: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoproliferative by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......53
Table 50: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS) by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......54
Table 51: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Non-Malignant Disorders by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......55
Table 52: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Plasma Cell Disorders by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......56
Table 53: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Solid Tumors by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......57
Table 54: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Americas (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Chronic Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS) and Others......58
Table 55: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Europe (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS), Non-Malignant Disorders and Others......59
Table 56: Number of β-thalassemia Patients for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) by Category in Europe (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow (BM), Mixed Chimerism, Peripheral Blood (PB), Unrelated Cord Blood Transplantation (UCB) and Uterine Natural Killer (UNK)......60
Haematopoietic Stem Cell Transplantation (HSCT)......61
Table 57: Haematopoietic Stem Cell Transplantation (HSCT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume for European Union, United States and Rest Of World......61
Human Leukocyte Antigen - Identical Sibling Stem Cells......62
Table 58: Human Leukocyte Antigen (HLA) - Identical Sibling Stem Cell Market by Disease Worldwide (2015) - Percentage Share Breakdown by Value for Graft-Versus-Host Disease, Infection, New Malignancy, Organ Failure, Primary Disease and Others......62
Stem Cells (Autologous)......63
Table 59: Autologous Stem Cell Market by Disease Worldwide (2015) - Percentage Share Breakdown by Value for Infection, New Malignancy, Organ Failure, Primary Disease and Others......63
Knee......64
Table 60: Global Knee Market by Value Sales (2015) - Percentage Share Breakdown for Biomet, Inc., DJO, LLC, Exactech, Inc., Johnson & Johnson, MAKO Surgical Corporation, Smith & Nephew Plc, Stryker Corporation, Tornier NV, Wright Medical Group, Inc., and Zimmer Holdings, Inc.......64
Table 61: Knee Procedures Sales by Region Worldwide (2015) - Percentage Share Breakdown by Value for US, and Others......65
Table 62: Knee Replacement Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Primary Knee Replacement, Revision Knee Replacement, Unicompartmental Knee Replacement, and Others......66
Table 63: Knee Replacement Market by Payor in the US (2015) - Percentage Share Breakdown by Value for Medicaid, Medicare, Private Insurance, and Others* (includes Uninsured)......67
Table 64: Knee Replacement Market by Type in the US (2015) - Percentage Share Breakdown by Value for Primary Knee Replacement, Revision Knee Replacement, and Unicompartmental Knee Replacement......68
Bone Marrow Stromal Cells......69
Table 65: Bone Marrow Stromal Cells by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for CD34+ and CD31-, Ebdothelial Cells, Stem Cells, Tissue Macrophages, Vascular Smooth Muscle Cells, and White Blood Cells......69
Genomics 2.0......70
Table 66: Market Shares of Leading Genomics 2.0 Service Providers in the US (2015) - Percentage Breakdown by Value for Illumina, Inc., Thermo Fisher Scientific Corporation, and Others......70
Knee......71
Table 67: Market Shares of Leading Knee Implant Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Biomet, Inc., Zimmer Holdings, Inc., Johnson & Johnson (JNJ), Smith & Nephew Plc (SNN), Stryker Corporation (SYK), and Others......71
Table 68: Market Shares of Leading Knee Implant Manufacturers by Value Sales in the US (2015) - Percentage Breakdown for Biomet, Inc., DePuy, Smith & Nephew Plc (SNN), Stryker Corporation, Wright Medical Group, Inc., and Zimmer Holdings, Inc.......72